C908
Active Member
FDA issues alert for isoxazoline class of flea, tick products
Potential exists for neurologic adverse events in dogs and cats when treated with isoxazoline class products
September 21, 2018
The U.S. Food and Drug Administration is alerting veterinarians and pet owners of the potential for neurologic adverse events in dogs and cats when treated with isoxazoline class flea and tick products, including Bravecto, Nexgard, and Simparica.
Potential exists for neurologic adverse events in dogs and cats when treated with isoxazoline class products
September 21, 2018
The U.S. Food and Drug Administration is alerting veterinarians and pet owners of the potential for neurologic adverse events in dogs and cats when treated with isoxazoline class flea and tick products, including Bravecto, Nexgard, and Simparica.
